Effects of Levosimendan on TNF-alpha, BNP and MMP-1 in Patients with Heart Failure with Anemia


Creative Commons License

BÜYÜKLÜ M., KURUM A. T., Tatli E., Set T.

ARQUIVOS BRASILEIROS DE CARDIOLOGIA, vol.99, no.1, pp.659-664, 2012 (SCI-Expanded) identifier identifier identifier

Abstract

Background: Levosimendan is known with its two-sided effects of strengthening myofibril contraction without increasing myocardial oxygen demand. Anemia is a deteriorating situation that causes increase of drug dosing in patients with heart failure.